Category Archives: Pharmacy

BELLEVUE, Wash., March 22, 2012 /PRNewswire/ -- Parkview Health, recognized as one of Indiana's leading provider of healthcare services, upgrades its pharmacy automation with Talyst's latest innovations. Parkview Health, a Talyst customer for almost 10 years, has implemented AutoPharm Enterprise, refrigerated AutoCarousel HD, AutoPack, and AutoLabel to enhance inventory control, increase workflow efficiency and improve patient safety. The upgrade is part of Parkview Regional Medical Center's expansion a newly built north-side hospital. "With Talyst technologies, Parkview Health has established a hub and spoke model redistributing to six pharmacies that are servicing eight hospitals," said Tim Cmelik, Director of Pharmacy at Parkview Health. "The products have improved medication management across our entire health system." "One of our goals is to deliver cutting-edge technology that improves our customers' pharmacy operations," said Carla Corkern, Chief Executive Officer at Talyst. "Our latest technologies continue to support our customers with that goal while also providing high quality service." About Parkview Health Parkview Health is a not-for-profit, community-based health system that serves northeast Indiana and northwest Ohio. Parkview is home to the region's first Verified Level II Adult and Pediatric Trauma Centers. Additional services include the Samaritan Flight Program, Parkview Heart Institute, Parkview Ortho Hospital, a … Continue reading →

KANSAS CITY, Mo., March 22, 2012 /PRNewswire/ --Argus Health Systems, Inc., a leading transparent pharmacy benefits administrator, today announced that it has established a Preferred Network with CVS/pharmacy, to provide expanded network options. This coordinated effort by Argus and CVS/pharmacy provides further alternatives in pharmacy networks for Argus customers. This agreement enables Argus to offer customers additional options in an alternative network. With the addition of CVS/pharmacy into the Preferred Network, Argus expands pharmacy access to its existing customer base. CVS/pharmacy, with more than 7,300 pharmacies across the U.S., has a level of national depth and access to care, while offering affordable medicines that can assist in preventing costly medical expenses. "When analyzing current pricing, we see a potential cost savings with an alternative network versus an open network," said Jonathan Boehm, president and CEO, Argus Health Systems. "Customers utilizing our alternative network options can generate potential savings, dependent on which network option is selected. Expanding the CVS access into a Preferred Network is an element of the overall Argus dedication to enhance all aspects of pharmacy benefit management and choices for our customers." Argus continues to expand the concept of alternative network options and continues to review contracting pharmacies … Continue reading →

ORLANDO, Fla., March 22, 2012 /PRNewswire/ --ARMSRx, LLC a pharmacy benefits consulting firm, held its annual conference March 7 9 at the Shores Resort and Spa, Daytona Beach, FL. This year's event "Speedway to Health" driven by the location and exclusive dinner venue located at the Daytona 500 Club, Daytona International Speedway, provided detailed advanced pharmacy benefit information as well as insight into the relation of pharmacy benefits and wellness. The focus started with; where and how disease states begin and how to prevent them in the first place. Jennifer Kingsley Wilson, CEO of ARMSRx, explained that the majority of disease states are caused by inflammation in the body. The topics built on each other beginning with the basics of genetic testing and risk factors, to the scientific breakthroughs to cure disease through Proteomics and finally how certain foods that you eat cause inflammation, leading to a multitude of disease conditions. Presenters included Dr. Jamie Wright, DO, FACOOG, ABAARM and twice Double Board Certified expert in Metabolic and Nutritional Medicine. Dr. Wright elaborated on the conclusive evidence associated with food intolerance, inflammation and disease. Dr. Edwin Lee, founder of the Institute of Hormonal Balance, enlightened the audience with a discussion … Continue reading →

Select a Publication: N E W S P A P E R S ---------------------------------------------- ---Alberta--- Airdrie - Airdrie Echo Banff - Banff Crag and Canyon Beaumont - Beaumont News Calgary - The Calgary Sun Camrose - Camrose Canadian Canmore - Canmore Leader Central Alberta - County Market Cochrane - Cochrane Times Cold Lake - Cold Lake Sun Crowsnest Pass - Crowsnest Pass Promoter Devon - Dispatch News Drayton - Drayton Valley Western Review Edmonton - Edmonton Examiner Edmonton - The Edmonton Sun Edson - Edson Leader Fairview - Fairview Post Fort McMurray - Fort McMurray Today Fort Saskatchewan - Fort Saskatchewan Record Grande Prairie - Daily Herald Tribune Hanna - Hanna Herald High River - High River Times Hinton - Hinton Parklander Lacombe - Lacombe Globe Leduc - Leduc Representative Lloydminster - Meridian Booster Mayerthorpe - Mayerthorpe Freelancer Nanton - Nanton News Peace Country - Peace Country Sun Peace River - Peace River Record Gazette Pincher Creek - Pincher Creek Echo Sherwood Park - Sherwood Park News Spruce Grove - Spruce Grove Examiner Stony Plain - Stony Plain Reporter Strathmore - Strathmore Standard Vermilion - Vermilion Standard Vulcan - Vulcan Advocate Wetaskiwin - Wetaskiwin Times Whitecourt - Whitecourt Star ---Manitoba--- … Continue reading →

Frustrated Massachusetts public health regulators pledged Wednesday to take their campaign for a ban on tobacco sales at pharmacies directly to state lawmakers and the Patrick administration. Five months ago, the state Public Health Council voted unanimously to direct administration officials to investigate the feasibility of prohibiting tobacco sales at drug stores, a measure now in place in about two dozen Massachusetts cities and towns. But with little evidence of movement on the issue, the council - an appointed panel of doctors, consumer advocates, and professors - decided Wednesday to press its case in a letter-writing campaign to Beacon Hill lawmakers. It is morally reprehensible for health care facilities . . . to continue to sell products that will kill a third of their patrons and drive the others to use their numerous pharmacies for their [smoking-related] illnesses, said Dr. Alan Woodward, past president of the Massachusetts Medical Society and a member of the Public Health Council. The initiative will include letters to the Legislature, the Patrick administration, and the states Board of Registration in Pharmacy, which regulates pharmacists, asking it to take all appropriate actions to end the sale of tobacco in pharmacies. Legislation to ban tobacco sales at … Continue reading →

By Anna Yukhananov WASHINGTON, March 21 (Reuters) - U.S. lawmakers are investigating three pharmacies in Maryland and North Carolina accused of passing critical drugs in short supply directly to wholesalers, who are likely to profit from the scarcity of life-saving medicines, rather than to the patients that need them. Elijah Cummings, the top Democrat on the influential House Committee on Oversight and Government Reform, began a probe in October to discover why certain companies were peddling cancer drugs at more than a hundred times their normal cost, while hospitals and patients were scrambling to receive any. The Food and Drug Administration has said the number of drugs in short supply, which include cancer, anesthesiology and nutrition medications, had risen to 220 in 2011 from 56 in 2006, the year a clear trend started emerging. Many of the drugs are generic, sterile injectable medications, such as cytarabine, a key treatment for leukemia, or fluorouracil, for colon and other cancers. According to details of the investigation made public on Wednesday, some wholesalers opened up their own phony pharmacies simply to get their hands on drugs in short supply and re-sell them to patients at possibly higher prices. In some cases, the pharmacy … Continue reading →

ATLANTA, March 21, 2012 /PRNewswire/ -- Broadspire, a Crawford Company and leading third party administrator (TPA) and medical management services provider, will bring together representatives from a number of key industry organizations to discuss challenges in prescription drug management for workers compensation claims during its first pharmacy summit Thursday. "The intention of the summit is to focus on global industry issues, trends and developments in the future," said Danielle Lisenbey, Broadspire's chief executive officer. "One of our key objectives is to help identify common threads that tie together claimant, payer, employer and carrier interests. We expect to share ideas that we can put into practice to improve outcomes for everyone concerned." More than 50 brokers, practice leaders, clinicians and others from major insurers, insurance brokerage firms and pharmacy benefit management (PBM) organizations will attend the summit, which will be held at Broadspire's Sunrise, Fla., medical management headquarters. Broadspire medical management personnel and representatives of the attending organizations will be featured speakers. The summit will include sessions on the following topics: Workers compensation prescription drug use is on the rise and accounts for 19 percent of all medical costs related to work comp claims, according to the National Council on Compensation … Continue reading →

WASHINGTON (Reuters) - Lawmakers are investigating three shadowy pharmacies in Maryland and North Carolina for diverting critical but scarce drugs from patients to wholesalers, who are then able to resell the medicine at sometimes big markups. Elijah Cummings, the senior Democrat on the House Committee on Oversight and Government Reform, began a probe in October to discover why certain companies were selling cancer drugs at more than a hundred times their normal cost. Shortages of hundreds of drugs including cisplatin, a highly effective treatment for testicular cancer, and fluorouracil for colon and other cancers have helped create a lucrative shadow market. The Food and Drug Administration has said the number of drugs in short supply, which also include anesthesiology and nutrition medications, had risen to 220 in 2011 from 56 in 2006. According to preliminary details of Cummings' investigation, made public on Wednesday, some wholesalers opened their own sham pharmacies to obtain drugs in short supply and re-sell them. One wholesaler increased the price tenfold from the pharmacy cost. "It's shocking to the conscience that anyone because of their greed would deny medicines to patients, who are in many instances in critical condition," Cummings said in an interview. "If it's … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Dublin - Research and Markets (http://www.researchandmarkets.com/research/783e792c/pharmacy_retail_ma) has announced the addition of the "Pharmacy Retail Market in India 2012" report to their offering. The Pharmacy Retail Market in India is a considerably big market already but has tremendous scope to grow further. Retail pharmacy outlets happens to be the most dominant distribution channel that is responsible for satisfying customer needs of pharmaceutical and allied products directly. The report begins with the introduction section that deals with the growing significance and work scope of pharmacy retailers followed by the various formats of stores prevalent in the country and the distribution channel from pharmacy manufacturer to the retailer. The market overview section provides an insight into the current and forecasted market size of the pharmacy retail market till 2016. The significance of retail outlets as the most popular pharmacy sales source is conceived from the market trend figures. The report is then provided with the driving factors that are encouraging the pharmacy retail market among which the growing pharmaceutical market finds a prominent position. Increased healthcare spending, changing disease profile, growing OTC segment, consumer's attitude towards their disease and illness and lucrative profit margins evolve as the possible reasons for the … Continue reading →

PLANO, Texas--(BUSINESS WIRE)-- Pharmaceutical Strategies Group, LLC (PSG), Americas largest independent pharmacy benefits consulting firm, has closed on its acquisition of Artemetrx Health Resources, the company announced today. Terms of the transaction were not disclosed. Artemetrx, whose technology was originally developed at the University of Kentucky, offers data analytic tools and clinical programs that integrate pharmacy, medical, and other healthcare information. PSGs clients have increasingly indicated their desire to have a more comprehensive view of patients clinical profiles in managing the prescription drug benefit. It is increasingly difficult to get a clear picture of why a medication is being used and to capture the total cost of care by just reviewing prescription claims data alone. This need is particularly acute for specialty medications, where 50% or more of the drug spend is not billed as a prescription, but as a medical claim, said Dave Borden, CEO of PSG. Joining PSG will be the senior management team of Artemetrx led by Dr. Brenda Motheral, Artemetrx's President, and Dr. John Langefeld, Chief Medical Officer. Dr. Motheral brings with her more than 15 years of experience in healthcare analytics and clinical program development, both in the pharmacy benefits management (PBM) and disease management … Continue reading →